Newsroom

SAN MATEO, Kalifornien--(BUSINESS WIRE)--Die Baszucki Group gab heute bekannt, dass sie eine Förderung in Höhe von 1,17 Millionen Pfund für eine randomisierte kontrollierte Studie an der Universität Oxford bereitstellt, in der die Durchführbarkeit, Sicherheit und Wirksamkeit einer ketogenen Diät bei Patienten mit einem hohen klinischen Psychoserisiko (CHR-P) untersucht werden soll. Die Forscher werden untersuchen, inwieweit diese Ernährungstherapie die geistige und körperliche Gesundheit der Pa...

SAN MATEO, Californie--(BUSINESS WIRE)--Baszucki Group a annoncé aujourd’hui l’octroi d’une subvention de 1,17 million GBP destinée à financer un essai contrôlé randomisé qui sera mené à l’université d’Oxford. Cet essai aura pour but d’évaluer la faisabilité, la sécurité et l’efficacité d’un régime cétogène chez des patients présentant un haut risque clinique de psychose (clinical high risk of psychosis CHR-P). Les chercheurs évalueront la capacité de cette thérapie nutritionnelle à améliorer l...

AUSTIN, Texas--(BUSINESS WIRE)--Amy Porterfield, John Lee, Dan Buettner, Shawn Johnson East, and Andrew East to headline KW’s CEO Summit....

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat)...

洛杉磯和韓國首爾--(BUSINESS WIRE)--(美國商業資訊)-- 今天，國際巨星Ahn Hyo-seop與多白金唱片歌手Khalid備受期待的跨界合作單曲《Something Special》正式發行，目前已透過FANDOM登陸各大主流串流媒體平台。如欲串流播放單曲，請點選此處。Musicow還將於6月發表官方MV，屆時將展現Ahn Hyo-seop與Khalid之間獨特的化學反應，同時在螢幕上生動呈現這場跨文化合作的魅力。 Ahn Hyo-seop因在Netflix爆款卡通片《K-Pop獵魔女團》(KPop Demon Hunters)中飾演惡魔男團「Saja Boys」的隊長「Jinu」一角而享譽全球。此次，他與曾獲葛萊美獎提名的歌手Khalid強強聯手，帶來了一首完美融合韓國流行音樂(K-pop)與美國節奏藍調(R&B)風格的跨流派作品。這兩種音樂流派正是當今重塑全球音樂文化最具影響力的力量。 《Something Special》由曾為傳奇K-pop組合Wonder Girls打造經典歌曲《Nobody》的Woo “RAINSTONE” Rhee操刀製作，並由...